Volume 18, Issue 3 p. 337-340
Clinical/Scientific Note

HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease

Marco Onofrj MD

Corresponding Author

Marco Onofrj MD

Department of Oncology and Neuroscience, Movement Disorders Center, Neurophysiopathology, Università G. D'Annunzio, Chieti-Pescara, Italy

Neurofisiopatologia, Ospedale Civile Spirito Santo, via Fonte Romana, 65124 Pescara, ItalySearch for more papers by this author
Anna Lisa Luciano MD

Anna Lisa Luciano MD

Department of Oncology and Neuroscience, Movement Disorders Center, Neurophysiopathology, Università G. D'Annunzio, Chieti-Pescara, Italy

Search for more papers by this author
Diego Iacono MD, PhD

Diego Iacono MD, PhD

Department of Oncology and Neuroscience, Movement Disorders Center, Neurophysiopathology, Università G. D'Annunzio, Chieti-Pescara, Italy

Search for more papers by this author
Astrid Thomas MD, PhD

Astrid Thomas MD, PhD

Department of Oncology and Neuroscience, Movement Disorders Center, Neurophysiopathology, Università G. D'Annunzio, Chieti-Pescara, Italy

Search for more papers by this author
Fabrizio Stocchi MD

Fabrizio Stocchi MD

Department of Oncology and Neuroscience, Movement Disorders Center, Neurophysiopathology, Università G. D'Annunzio, Chieti-Pescara, Italy

Search for more papers by this author
Franco Papola PhD

Franco Papola PhD

Regional Center for Immunohaematology and Tissue Typing, National Council of Research, L'Aquila, Italy

Search for more papers by this author
Domenico Adorno MD

Domenico Adorno MD

Regional Center for Immunohaematology and Tissue Typing, National Council of Research, L'Aquila, Italy

Search for more papers by this author
Rocco Di Mascio MD, PhD

Rocco Di Mascio MD, PhD

Institute of Medical Statistics. Università G. D'Annunzio, Chieti-Pescara, Italy

Search for more papers by this author
First published: 13 November 2002
Citations: 17

Abstract

HLA-DR2 haplotype and DQ1 DNA alleles, characterizing 90 to 100% of all narcoleptic patients, were found to be equally distributed in 20 Parkinson's disease (PD) patients with early hallucinations, rapid eye movement (REM) sleep-related behaviour disturbances (RBD), and sleep onset in REM (SOREM), and in 20 PD patients without hallucinations, despite 10 to 15 years of treatment, and no RBD or SOREM.